The gene-editing therapy Casgevy (exagamglogene autotemcel) safely and effectively prevents vaso-occlusive crises (VOCs) in children as young as…
Articles by Marisa Wexler, MS
As part of a program to support children with sickle cell disease (SCD) and cancers, supplemental insurance company…
Disc Medicine says it’s planning to launch a clinical trial before the end of the year that will test…
A blood test measuring a protein called placental growth factor (PlGF) may help identify women with sickle cell disease…
People with sickle cell disease (SCD) seeking emergency care for vaso-occlusive crises (VOCs) are often not triaged appropriately,…
Mortality rates related to sickle cell disease (SCD) have increased in the U.S. in recent decades, while mortality for…
Scientists at New York University (NYU) are teaming up with Nigerian-born music artist Adekunle Gold on a project to improve…
Young people with sickle cell disease (SCD) who live in areas with more air pollution are more likely to…
People with severe sickle cell disease (SCD) have reported significant improvements in their quality of life after receiving the…
Correctsequence Therapeutics’ experimental gene-editing therapy CS-101 has been used to treat a person with sickle cell disease (SCD) for…